Thank You for Joining Waters at ADLM 2026
Advancing Diagnostics Through Innovative Technologies. Together.
Thank you for connecting with Waters at ADLM 2026 in Anaheim.
This year marked an exciting milestone as we showcased the combined strengths of BD’s Diagnostic Solutions and Biosciences businesses and Waters Corporation. Together, we demonstrated how our expanded portfolio, scientific expertise, and innovative technologies can help laboratories improve efficiency, enhance diagnostic confidence, and advance patient care.
Whether you visited our booth, attended one of our educational events, met with our experts, or were unable to join us in Anaheim, we invite you to continue exploring the latest innovations from Waters.
Explore Our ADLM 2026 Highlights
At ADLM 2026, attendees experienced innovative technologies and solutions spanning:
- Molecular diagnostics
- Bloodstream infection solutions
- Identification and antimicrobial susceptibility testing (ID/AST)
- Laboratory informatics and workflow connectivity
- Automation and laboratory efficiency solutions
- Advanced cellular analysis and flow cytometry solutions
- Clinical LC-MS/MS
Together, these solutions are designed to help laboratories address evolving diagnostic needs, optimize workflows, and deliver greater confidence across the continuum of patient care.
Introducing the Xevo™ TQ Absolute XR IVD Mass Spectrometer
Greater Confidence. Exceptional Performance. Designed for the Clinical Laboratory.
ADLM attendees were among the first to experience the Xevo™ TQ Absolute XR IVD Mass Spectrometer—designed to help clinical laboratories meet evolving testing demands with exceptional analytical sensitivity, enhanced robustness, and greater operational efficiency.
Powered by StepWave™ XR ion guide technology, the Xevo TQ Absolute XR IVD delivers the analytical performance and long-term reliability needed to confidently expand clinical LC-MS/MS testing while helping laboratories maximize productivity and optimize valuable laboratory space.
Discover the BD BACTEC™ FXI Culture System
Designed for the realities of today’s clinical microbiology labs, the BD BACTEC™ FXI Culture System unites proven clinical performance, advanced automation, streamlined workflows, and scalable capacity.
Explore Our Expanded Diagnostic Solutions Portfolio
As one company, Waters brings together complementary technologies, scientific expertise, and workflow solutions across clinical diagnostics and life sciences.
Explore solutions designed to support your laboratory’s evolving needs:
Clinical LC-MS/MS Solutions
Advance analytical confidence and laboratory efficiency with clinical LC-MS/MS technologies, including:
- Xevo™ TQ Absolute XR IVD Mass Spectrometer
- Xevo™ TQD IVD Mass Spectrometer
- ACQUITY™ UPLC™ I-Class PLUS IVD System
- MassTrak™ Clinical Reagents
- waters_connect™ Software
Molecular Diagnostics
The molecular diagnostics portfolio offers a comprehensive molecular diagnostics ecosystem—designed to support labs across testing volumes, workflows, and clinical needs.
- BD COR™ System
- BD MAX™ System
- Onclarity™ Self-Collection Kit for At-Home
Microbiology Solutions
Built to provide world-class, end-to-end, differentiated results for infectious diseases, in the right site of care at the right time.
- BD™ BACTEC™ FXI Culture System
- BD Phoenix™ M50 Automated Microbiology System
- BD Bruker MALDI® Biotyper
- BD Kiestra™ Laboratory Automation Solutions
- BD BACTEC MGIT II
- BD Synapsys™ Informatics Solutions
Thank You for Making ADLM 2026 a Success
Thank you to everyone who visited our booth, participated in our educational events, connected with our experts, and helped make ADLM 2026 a memorable experience.
We look forward to continuing our collaboration and working together to advance the future of diagnostics.
Waters Corporation has acquired BD Biosciences and BD Diagnostic Solutions. BD remains the legal manufacturer until all required regulatory transfers are complete. Learn more at: waters.com/bdtransaction